Using tDCS in Speech-based Stroke Rehabilitation
| Status: | Not yet recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - 99 |
| Updated: | 1/11/2019 |
| Start Date: | April 2019 |
| End Date: | December 2019 |
| Contact: | Rebecca Wellner |
| Email: | rebecca.wellner@nyumc.org |
| Phone: | 202-669-0188 |
The purpose of this study is to determine whether the effect of treatment for acquired speech
impairment can be enhanced by combining effective behavioral treatment with non-invasive
brain stimulation. Transcranial direct current stimulation (tDCS), which delivers
low-intensity current to the scalp, and is a safe and well-tolerated approach that poses a
non-significant risk to participants. tDCS provides low intensity neural stimulation which
has been shown to facilitate motor learning in other domains of stroke rehabilitation such as
arm motor learning but the potential to enhance speech motor learning has not been explored.
This will be examined with a series of single-case experimental designs.
impairment can be enhanced by combining effective behavioral treatment with non-invasive
brain stimulation. Transcranial direct current stimulation (tDCS), which delivers
low-intensity current to the scalp, and is a safe and well-tolerated approach that poses a
non-significant risk to participants. tDCS provides low intensity neural stimulation which
has been shown to facilitate motor learning in other domains of stroke rehabilitation such as
arm motor learning but the potential to enhance speech motor learning has not been explored.
This will be examined with a series of single-case experimental designs.
Inclusion Criteria:
- Right-handed
- Monolingual (English)
- Single left-hemisphere CVA
- A minimum of six months post-stroke
- Clinical diagnosis of apraxia of speech
- Normal speech perception
- Passing score on the hearing screening.
Exclusion Criteria:
- Diagnosis of laryngeal voice disorder
- Dysarthria
- History of speech impairment prior to CVA
- Presence of potential tDCS risk factors: damaged skin at site of stimulation;
- Presence of electrically or magnetically activated implant (including pacemaker);
- metal in any part of their body;
- history of medication-resistant epilepsy in the family;
- past history of seizures or unexplained spells of loss of consciousness.
We found this trial at
1
site
550 1st Ave
New York, New York 10016
New York, New York 10016
(212) 263-7300
Principal Investigator: Adam Buchwald, MD
Phone: 202-669-0188
New York University School of Medicine NYU School of Medicine has a proud history that...
Click here to add this to my saved trials
